GO:0090304 | nucleic acid metabolic process | 16.59% (34/205) | 1.92 | 0.0 | 0.0 |
GO:0003676 | nucleic acid binding | 24.88% (51/205) | 1.46 | 0.0 | 0.0 |
GO:0005488 | binding | 51.71% (106/205) | 0.71 | 0.0 | 0.0 |
GO:0006139 | nucleobase-containing compound metabolic process | 17.07% (35/205) | 1.66 | 0.0 | 0.0 |
GO:0046483 | heterocycle metabolic process | 17.07% (35/205) | 1.54 | 0.0 | 2e-06 |
GO:0006725 | cellular aromatic compound metabolic process | 17.07% (35/205) | 1.52 | 0.0 | 2e-06 |
GO:1901360 | organic cyclic compound metabolic process | 17.07% (35/205) | 1.49 | 0.0 | 3e-06 |
GO:0006259 | DNA metabolic process | 8.78% (18/205) | 2.24 | 0.0 | 5e-06 |
GO:0034641 | cellular nitrogen compound metabolic process | 18.54% (38/205) | 1.35 | 0.0 | 5e-06 |
GO:0140513 | nuclear protein-containing complex | 6.34% (13/205) | 2.77 | 0.0 | 6e-06 |
GO:0043170 | macromolecule metabolic process | 27.8% (57/205) | 0.98 | 0.0 | 1.4e-05 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 9.27% (19/205) | 1.97 | 1e-06 | 2.7e-05 |
GO:0004518 | nuclease activity | 4.39% (9/205) | 3.16 | 1e-06 | 4.3e-05 |
GO:0097159 | organic cyclic compound binding | 33.17% (68/205) | 0.8 | 1e-06 | 4.6e-05 |
GO:0007017 | microtubule-based process | 4.39% (9/205) | 3.02 | 2e-06 | 8.4e-05 |
GO:0032991 | protein-containing complex | 12.2% (25/205) | 1.51 | 3e-06 | 0.000103 |
GO:1902494 | catalytic complex | 6.34% (13/205) | 2.3 | 3e-06 | 0.000109 |
GO:0005515 | protein binding | 22.44% (46/205) | 0.99 | 4e-06 | 0.000126 |
GO:0022402 | cell cycle process | 3.41% (7/205) | 3.4 | 5e-06 | 0.000167 |
GO:0070603 | SWI/SNF superfamily-type complex | 1.95% (4/205) | 5.01 | 7e-06 | 0.000216 |
GO:0043414 | macromolecule methylation | 2.93% (6/205) | 3.7 | 7e-06 | 0.00022 |
GO:1904949 | ATPase complex | 1.95% (4/205) | 4.95 | 8e-06 | 0.000232 |
GO:0006302 | double-strand break repair | 1.95% (4/205) | 4.89 | 1e-05 | 0.000262 |
GO:0006807 | nitrogen compound metabolic process | 27.8% (57/205) | 0.8 | 1.2e-05 | 0.0003 |
GO:0015631 | tubulin binding | 3.9% (8/205) | 2.93 | 1.2e-05 | 0.000302 |
GO:0006974 | DNA damage response | 6.34% (13/205) | 2.11 | 1.2e-05 | 0.000311 |
GO:0003674 | molecular_function | 66.83% (137/205) | 0.36 | 1.5e-05 | 0.000338 |
GO:0003723 | RNA binding | 8.29% (17/205) | 1.68 | 2.7e-05 | 0.000567 |
GO:0097255 | R2TP complex | 0.98% (2/205) | 7.59 | 2.7e-05 | 0.000578 |
GO:0005575 | cellular_component | 22.44% (46/205) | 0.88 | 2.7e-05 | 0.000593 |
GO:0033554 | cellular response to stress | 6.34% (13/205) | 1.99 | 3e-05 | 0.000602 |
GO:0032259 | methylation | 2.93% (6/205) | 3.32 | 3.4e-05 | 0.000655 |
GO:0051716 | cellular response to stimulus | 6.34% (13/205) | 1.96 | 3.7e-05 | 0.000687 |
GO:1990234 | transferase complex | 3.9% (8/205) | 2.7 | 3.6e-05 | 0.000691 |
GO:0004519 | endonuclease activity | 2.44% (5/205) | 3.7 | 4.3e-05 | 0.00075 |
GO:0000226 | microtubule cytoskeleton organization | 2.44% (5/205) | 3.7 | 4.3e-05 | 0.00075 |
GO:0008092 | cytoskeletal protein binding | 4.39% (9/205) | 2.44 | 4.8e-05 | 0.000795 |
GO:0035267 | NuA4 histone acetyltransferase complex | 1.46% (3/205) | 5.37 | 4.8e-05 | 0.000812 |
GO:0016570 | histone modification | 2.44% (5/205) | 3.65 | 5.2e-05 | 0.000817 |
GO:0006281 | DNA repair | 5.85% (12/205) | 2.01 | 5.1e-05 | 0.000818 |
GO:1902493 | acetyltransferase complex | 1.95% (4/205) | 4.23 | 6.1e-05 | 0.000853 |
GO:0031248 | protein acetyltransferase complex | 1.95% (4/205) | 4.23 | 6.1e-05 | 0.000853 |
GO:0008017 | microtubule binding | 3.41% (7/205) | 2.86 | 5.7e-05 | 0.000869 |
GO:1902562 | H4 histone acetyltransferase complex | 1.46% (3/205) | 5.27 | 6e-05 | 0.00087 |
GO:0043189 | H4/H2A histone acetyltransferase complex | 1.46% (3/205) | 5.27 | 6e-05 | 0.00087 |
GO:0016070 | RNA metabolic process | 7.8% (16/205) | 1.6 | 8.8e-05 | 0.001199 |
GO:0043687 | post-translational protein modification | 4.39% (9/205) | 2.32 | 9.4e-05 | 0.001249 |
GO:0043412 | macromolecule modification | 13.17% (27/205) | 1.11 | 0.000143 | 0.001824 |
GO:0009987 | cellular process | 35.12% (72/205) | 0.57 | 0.000143 | 0.001857 |
GO:0030870 | Mre11 complex | 0.98% (2/205) | 6.59 | 0.00016 | 0.00192 |
GO:0042770 | signal transduction in response to DNA damage | 0.98% (2/205) | 6.59 | 0.00016 | 0.00192 |
GO:0000077 | DNA damage checkpoint signaling | 0.98% (2/205) | 6.59 | 0.00016 | 0.00192 |
GO:0140535 | intracellular protein-containing complex | 3.9% (8/205) | 2.37 | 0.000183 | 0.002116 |
GO:0004540 | RNA nuclease activity | 2.44% (5/205) | 3.27 | 0.000181 | 0.002135 |
GO:0140657 | ATP-dependent activity | 6.83% (14/205) | 1.61 | 0.000235 | 0.002676 |
GO:0043227 | membrane-bounded organelle | 6.34% (13/205) | 1.66 | 0.000283 | 0.003106 |
GO:0043231 | intracellular membrane-bounded organelle | 6.34% (13/205) | 1.66 | 0.000283 | 0.003106 |
GO:0005634 | nucleus | 5.37% (11/205) | 1.81 | 0.000353 | 0.003802 |
GO:0009451 | RNA modification | 2.93% (6/205) | 2.69 | 0.000362 | 0.003838 |
GO:0140098 | catalytic activity, acting on RNA | 4.39% (9/205) | 2.04 | 0.000398 | 0.003944 |
GO:0031570 | DNA integrity checkpoint signaling | 0.98% (2/205) | 6.01 | 0.000397 | 0.003998 |
GO:0031213 | RSF complex | 0.98% (2/205) | 6.01 | 0.000397 | 0.003998 |
GO:0031010 | ISWI-type complex | 0.98% (2/205) | 6.01 | 0.000397 | 0.003998 |
GO:0007010 | cytoskeleton organization | 2.44% (5/205) | 2.99 | 0.000438 | 0.004275 |
GO:0042393 | histone binding | 1.46% (3/205) | 4.32 | 0.000456 | 0.004382 |
GO:0098687 | chromosomal region | 0.98% (2/205) | 5.78 | 0.000553 | 0.00524 |
GO:0003677 | DNA binding | 10.73% (22/205) | 1.1 | 0.000649 | 0.006056 |
GO:0006996 | organelle organization | 5.37% (11/205) | 1.69 | 0.000707 | 0.006494 |
GO:0001510 | RNA methylation | 1.46% (3/205) | 4.09 | 0.000732 | 0.006632 |
GO:0022414 | reproductive process | 1.95% (4/205) | 3.3 | 0.000745 | 0.006647 |
GO:0003697 | single-stranded DNA binding | 1.46% (3/205) | 4.05 | 0.000798 | 0.007023 |
GO:0000123 | histone acetyltransferase complex | 1.46% (3/205) | 4.01 | 0.000867 | 0.007526 |
GO:0140097 | catalytic activity, acting on DNA | 4.39% (9/205) | 1.86 | 0.000946 | 0.007992 |
GO:1903046 | meiotic cell cycle process | 1.46% (3/205) | 3.97 | 0.00094 | 0.008047 |
GO:0042162 | telomeric DNA binding | 0.98% (2/205) | 5.27 | 0.001174 | 0.009781 |
GO:0044238 | primary metabolic process | 27.8% (57/205) | 0.55 | 0.001379 | 0.01105 |
GO:0003777 | microtubule motor activity | 1.95% (4/205) | 3.07 | 0.001378 | 0.011188 |
GO:0007018 | microtubule-based movement | 1.95% (4/205) | 3.07 | 0.001378 | 0.011188 |
GO:0004523 | RNA-DNA hybrid ribonuclease activity | 0.98% (2/205) | 5.01 | 0.00171 | 0.013357 |
GO:1905354 | exoribonuclease complex | 0.98% (2/205) | 5.01 | 0.00171 | 0.013357 |
GO:0004521 | RNA endonuclease activity | 1.46% (3/205) | 3.65 | 0.001774 | 0.013691 |
GO:0033169 | histone H3-K9 demethylation | 0.98% (2/205) | 4.89 | 0.002014 | 0.014301 |
GO:0016577 | histone demethylation | 0.98% (2/205) | 4.89 | 0.002014 | 0.014301 |
GO:0070076 | histone lysine demethylation | 0.98% (2/205) | 4.89 | 0.002014 | 0.014301 |
GO:0032454 | histone H3K9 demethylase activity | 0.98% (2/205) | 4.89 | 0.002014 | 0.014301 |
GO:0032452 | histone demethylase activity | 0.98% (2/205) | 4.89 | 0.002014 | 0.014301 |
GO:0141052 | histone H3 demethylase activity | 0.98% (2/205) | 4.89 | 0.002014 | 0.014301 |
GO:0140457 | protein demethylase activity | 0.98% (2/205) | 4.89 | 0.002014 | 0.014301 |
GO:0006479 | protein methylation | 1.46% (3/205) | 3.56 | 0.002129 | 0.014786 |
GO:0008213 | protein alkylation | 1.46% (3/205) | 3.56 | 0.002129 | 0.014786 |
GO:0005524 | ATP binding | 12.68% (26/205) | 0.87 | 0.002195 | 0.015076 |
GO:0006482 | protein demethylation | 0.98% (2/205) | 4.78 | 0.002341 | 0.015734 |
GO:0008214 | protein dealkylation | 0.98% (2/205) | 4.78 | 0.002341 | 0.015734 |
GO:1901988 | negative regulation of cell cycle phase transition | 0.98% (2/205) | 4.68 | 0.002692 | 0.017347 |
GO:0010948 | negative regulation of cell cycle process | 0.98% (2/205) | 4.68 | 0.002692 | 0.017347 |
GO:0000075 | cell cycle checkpoint signaling | 0.98% (2/205) | 4.68 | 0.002692 | 0.017347 |
GO:0071840 | cellular component organization or biogenesis | 7.32% (15/205) | 1.19 | 0.002752 | 0.017554 |
GO:0008150 | biological_process | 46.83% (96/205) | 0.34 | 0.002641 | 0.017559 |
GO:0003774 | cytoskeletal motor activity | 1.95% (4/205) | 2.76 | 0.003013 | 0.019024 |
GO:1902911 | protein kinase complex | 0.98% (2/205) | 4.59 | 0.003066 | 0.019164 |
GO:0016043 | cellular component organization | 6.83% (14/205) | 1.21 | 0.003197 | 0.019782 |
GO:0007051 | spindle organization | 0.98% (2/205) | 4.5 | 0.003463 | 0.021221 |
GO:0044237 | cellular metabolic process | 22.44% (46/205) | 0.57 | 0.00357 | 0.021661 |
GO:0097346 | INO80-type complex | 0.98% (2/205) | 4.42 | 0.003883 | 0.023113 |
GO:0031011 | Ino80 complex | 0.98% (2/205) | 4.42 | 0.003883 | 0.023113 |
GO:0032559 | adenyl ribonucleotide binding | 12.68% (26/205) | 0.8 | 0.004185 | 0.023996 |
GO:0043229 | intracellular organelle | 7.8% (16/205) | 1.08 | 0.004182 | 0.024202 |
GO:0043226 | organelle | 7.8% (16/205) | 1.08 | 0.004182 | 0.024202 |
GO:0016579 | protein deubiquitination | 1.46% (3/205) | 3.2 | 0.004352 | 0.024503 |
GO:0070988 | demethylation | 0.98% (2/205) | 4.34 | 0.004325 | 0.024574 |
GO:0071704 | organic substance metabolic process | 28.29% (58/205) | 0.47 | 0.004176 | 0.024623 |
GO:0018193 | peptidyl-amino acid modification | 1.95% (4/205) | 2.6 | 0.00443 | 0.024723 |
GO:0043139 | 5'-3' DNA helicase activity | 0.49% (1/205) | 7.59 | 0.00519 | 0.02616 |
GO:0000212 | meiotic spindle organization | 0.49% (1/205) | 7.59 | 0.00519 | 0.02616 |
GO:0007095 | mitotic G2 DNA damage checkpoint signaling | 0.49% (1/205) | 7.59 | 0.00519 | 0.02616 |
GO:0030289 | protein phosphatase 4 complex | 0.49% (1/205) | 7.59 | 0.00519 | 0.02616 |
GO:0016633 | galactonolactone dehydrogenase activity | 0.49% (1/205) | 7.59 | 0.00519 | 0.02616 |
GO:0090730 | Las1 complex | 0.49% (1/205) | 7.59 | 0.00519 | 0.02616 |
GO:0030620 | U2 snRNA binding | 0.49% (1/205) | 7.59 | 0.00519 | 0.02616 |
GO:0044773 | mitotic DNA damage checkpoint signaling | 0.49% (1/205) | 7.59 | 0.00519 | 0.02616 |
GO:0016632 | oxidoreductase activity, acting on the CH-CH group of donors, cytochrome as acceptor | 0.49% (1/205) | 7.59 | 0.00519 | 0.02616 |
GO:0006473 | protein acetylation | 0.98% (2/205) | 4.2 | 0.005275 | 0.026377 |
GO:0035639 | purine ribonucleoside triphosphate binding | 13.17% (27/205) | 0.77 | 0.004802 | 0.026559 |
GO:0008094 | ATP-dependent activity, acting on DNA | 3.41% (7/205) | 1.76 | 0.004908 | 0.026911 |
GO:0070646 | protein modification by small protein removal | 1.46% (3/205) | 3.11 | 0.005171 | 0.028102 |
GO:0032451 | demethylase activity | 0.98% (2/205) | 4.13 | 0.005783 | 0.028686 |
GO:0036211 | protein modification process | 10.24% (21/205) | 0.86 | 0.006066 | 0.029853 |
GO:1903293 | phosphatase complex | 0.98% (2/205) | 4.07 | 0.006312 | 0.030348 |
GO:0008287 | protein serine/threonine phosphatase complex | 0.98% (2/205) | 4.07 | 0.006312 | 0.030348 |
GO:0045786 | negative regulation of cell cycle | 0.98% (2/205) | 4.07 | 0.006312 | 0.030348 |
GO:0006913 | nucleocytoplasmic transport | 1.46% (3/205) | 2.99 | 0.006563 | 0.031311 |
GO:0051169 | nuclear transport | 1.46% (3/205) | 2.95 | 0.007071 | 0.033482 |
GO:0043543 | protein acylation | 0.98% (2/205) | 3.95 | 0.007434 | 0.034165 |
GO:1901987 | regulation of cell cycle phase transition | 0.98% (2/205) | 3.95 | 0.007434 | 0.034165 |
GO:0008168 | methyltransferase activity | 2.93% (6/205) | 1.83 | 0.007361 | 0.034335 |
GO:0004843 | cysteine-type deubiquitinase activity | 1.46% (3/205) | 2.93 | 0.007334 | 0.034466 |
GO:0016788 | hydrolase activity, acting on ester bonds | 5.37% (11/205) | 1.22 | 0.008282 | 0.037781 |
GO:0032555 | purine ribonucleotide binding | 13.17% (27/205) | 0.7 | 0.008408 | 0.038078 |
GO:1902750 | negative regulation of cell cycle G2/M phase transition | 0.49% (1/205) | 6.59 | 0.010353 | 0.038289 |
GO:0043564 | Ku70:Ku80 complex | 0.49% (1/205) | 6.59 | 0.010353 | 0.038289 |
GO:0008296 | 3'-5'-DNA exonuclease activity | 0.49% (1/205) | 6.59 | 0.010353 | 0.038289 |
GO:0010389 | regulation of G2/M transition of mitotic cell cycle | 0.49% (1/205) | 6.59 | 0.010353 | 0.038289 |
GO:0004799 | thymidylate synthase activity | 0.49% (1/205) | 6.59 | 0.010353 | 0.038289 |
GO:0035299 | inositol pentakisphosphate 2-kinase activity | 0.49% (1/205) | 6.59 | 0.010353 | 0.038289 |
GO:0006231 | dTMP biosynthetic process | 0.49% (1/205) | 6.59 | 0.010353 | 0.038289 |
GO:0042083 | 5,10-methylenetetrahydrofolate-dependent methyltransferase activity | 0.49% (1/205) | 6.59 | 0.010353 | 0.038289 |
GO:0030896 | checkpoint clamp complex | 0.49% (1/205) | 6.59 | 0.010353 | 0.038289 |
GO:0098847 | sequence-specific single stranded DNA binding | 0.49% (1/205) | 6.59 | 0.010353 | 0.038289 |
GO:0043047 | single-stranded telomeric DNA binding | 0.49% (1/205) | 6.59 | 0.010353 | 0.038289 |
GO:0000781 | chromosome, telomeric region | 0.49% (1/205) | 6.59 | 0.010353 | 0.038289 |
GO:0045144 | meiotic sister chromatid segregation | 0.49% (1/205) | 6.59 | 0.010353 | 0.038289 |
GO:0043968 | histone H2A acetylation | 0.49% (1/205) | 6.59 | 0.010353 | 0.038289 |
GO:0034086 | maintenance of sister chromatid cohesion | 0.49% (1/205) | 6.59 | 0.010353 | 0.038289 |
GO:0008353 | RNA polymerase II CTD heptapeptide repeat kinase activity | 0.49% (1/205) | 6.59 | 0.010353 | 0.038289 |
GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity | 0.49% (1/205) | 6.59 | 0.010353 | 0.038289 |
GO:0044774 | mitotic DNA integrity checkpoint signaling | 0.49% (1/205) | 6.59 | 0.010353 | 0.038289 |
GO:0044818 | mitotic G2/M transition checkpoint | 0.49% (1/205) | 6.59 | 0.010353 | 0.038289 |
GO:0070985 | transcription factor TFIIK complex | 0.49% (1/205) | 6.59 | 0.010353 | 0.038289 |
GO:1902749 | regulation of cell cycle G2/M phase transition | 0.49% (1/205) | 6.59 | 0.010353 | 0.038289 |
GO:0046073 | dTMP metabolic process | 0.49% (1/205) | 6.59 | 0.010353 | 0.038289 |
GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle | 0.49% (1/205) | 6.59 | 0.010353 | 0.038289 |
GO:0043967 | histone H4 acetylation | 0.49% (1/205) | 6.59 | 0.010353 | 0.038289 |
GO:0034090 | maintenance of meiotic sister chromatid cohesion | 0.49% (1/205) | 6.59 | 0.010353 | 0.038289 |
GO:0061695 | transferase complex, transferring phosphorus-containing groups | 1.46% (3/205) | 2.73 | 0.010609 | 0.038328 |
GO:0097367 | carbohydrate derivative binding | 13.17% (27/205) | 0.68 | 0.010474 | 0.038509 |
GO:0016893 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 0.98% (2/205) | 3.68 | 0.010598 | 0.038511 |
GO:0018024 | obsolete histone lysine N-methyltransferase activity | 0.98% (2/205) | 3.68 | 0.010598 | 0.038511 |
GO:0030554 | adenyl nucleotide binding | 12.68% (26/205) | 0.71 | 0.008706 | 0.039144 |
GO:0016741 | transferase activity, transferring one-carbon groups | 2.93% (6/205) | 1.7 | 0.010906 | 0.039175 |
GO:0006260 | DNA replication | 1.95% (4/205) | 2.21 | 0.011425 | 0.040802 |
GO:0110165 | cellular anatomical entity | 13.66% (28/205) | 0.65 | 0.011603 | 0.041205 |
GO:0016891 | RNA endonuclease activity, producing 5'-phosphomonoesters | 0.98% (2/205) | 3.78 | 0.009272 | 0.041393 |
GO:0032553 | ribonucleotide binding | 13.17% (27/205) | 0.69 | 0.009485 | 0.042044 |
GO:0006396 | RNA processing | 3.41% (7/205) | 1.51 | 0.012058 | 0.04234 |
GO:0017056 | structural constituent of nuclear pore | 0.98% (2/205) | 3.59 | 0.012003 | 0.042382 |
GO:0000166 | nucleotide binding | 14.15% (29/205) | 0.65 | 0.009956 | 0.043515 |
GO:1901265 | nucleoside phosphate binding | 14.15% (29/205) | 0.65 | 0.009956 | 0.043515 |
GO:0006397 | mRNA processing | 1.95% (4/205) | 2.16 | 0.012616 | 0.044051 |
GO:0006950 | response to stress | 6.34% (13/205) | 1.06 | 0.010168 | 0.044131 |
GO:0031123 | RNA 3'-end processing | 0.98% (2/205) | 3.5 | 0.013484 | 0.046819 |
GO:0000398 | mRNA splicing, via spliceosome | 1.46% (3/205) | 2.59 | 0.013825 | 0.047739 |
GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process | 0.49% (1/205) | 6.01 | 0.01549 | 0.048166 |
GO:0070192 | chromosome organization involved in meiotic cell cycle | 0.49% (1/205) | 6.01 | 0.01549 | 0.048166 |
GO:0010496 | intercellular transport | 0.49% (1/205) | 6.01 | 0.01549 | 0.048166 |
GO:0009162 | deoxyribonucleoside monophosphate metabolic process | 0.49% (1/205) | 6.01 | 0.01549 | 0.048166 |
GO:0009177 | pyrimidine deoxyribonucleoside monophosphate biosynthetic process | 0.49% (1/205) | 6.01 | 0.01549 | 0.048166 |
GO:0009176 | pyrimidine deoxyribonucleoside monophosphate metabolic process | 0.49% (1/205) | 6.01 | 0.01549 | 0.048166 |
GO:0034518 | RNA cap binding complex | 0.49% (1/205) | 6.01 | 0.01549 | 0.048166 |
GO:0005876 | spindle microtubule | 0.49% (1/205) | 6.01 | 0.01549 | 0.048166 |
GO:0000339 | RNA cap binding | 0.49% (1/205) | 6.01 | 0.01549 | 0.048166 |
GO:0043240 | Fanconi anaemia nuclear complex | 0.49% (1/205) | 6.01 | 0.01549 | 0.048166 |
GO:0006303 | double-strand break repair via nonhomologous end joining | 0.49% (1/205) | 6.01 | 0.01549 | 0.048166 |
GO:0010497 | plasmodesmata-mediated intercellular transport | 0.49% (1/205) | 6.01 | 0.01549 | 0.048166 |
GO:0017196 | N-terminal peptidyl-methionine acetylation | 0.49% (1/205) | 6.01 | 0.01549 | 0.048166 |
GO:0005846 | nuclear cap binding complex | 0.49% (1/205) | 6.01 | 0.01549 | 0.048166 |
GO:0018206 | peptidyl-methionine modification | 0.49% (1/205) | 6.01 | 0.01549 | 0.048166 |
GO:0031417 | NatC complex | 0.49% (1/205) | 6.01 | 0.01549 | 0.048166 |
GO:0019888 | protein phosphatase regulator activity | 0.98% (2/205) | 3.46 | 0.014253 | 0.048945 |
GO:0008152 | metabolic process | 28.29% (58/205) | 0.38 | 0.016011 | 0.049539 |